Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Horst Zerbe"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Multiple Sclerosis (MS) is a multifactorial autoimmune disease of the central nervous system (CNS). It is characterized by a heightened activation of the immune system with ensuing inflammation, demyelination and neurodegeneration with consequences s
Externí odkaz:
https://doaj.org/article/bb0776e3fcc847c4af11a8553cf9212b
Autor:
Ludwig Aigner, Frank Pietrantonio, Diana Marisa Bessa de Sousa, Johanna Michael, Daniela Schuster, Herbert Anton Reitsamer, Horst Zerbe, Michael Studnicka
Publikováno v:
Frontiers in Molecular Biosciences, Vol 7 (2020)
The emergence and global impact of COVID-19 has focused the scientific and medical community on the pivotal influential role of respiratory viruses as causes of severe pneumonia, on the understanding of the underlying pathomechanisms, and on potentia
Externí odkaz:
https://doaj.org/article/abbe64e553144879a3249cb3e45c1936
Autor:
Johanna Michael, Julia Zirknitzer, Michael Stefan Unger, Rodolphe Poupardin, Tanja Rieß, Nadine Paiement, Horst Zerbe, Birgit Hutter-Paier, Herbert Reitsamer, Ludwig Aigner
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 5, p 2782 (2021)
Alzheimer’s disease (AD) is the most common form of dementia. In particular, neuroinflammation, mediated by microglia cells but also through CD8+ T-cells, actively contributes to disease pathology. Leukotrienes are involved in neuroinflammation and
Externí odkaz:
https://doaj.org/article/a6969676b23748eb97b4f3c1f255a0ec
Autor:
Johanna Michael, Diana Bessa de Sousa, Justin Conway, Erick Gonzalez-Labrada, Rodolphe Obeid, Julia Tevini, Thomas Felder, Birgit Hutter-Paier, Horst Zerbe, Nadine Paiement, Ludwig Aigner
Publikováno v:
Pharmaceutics, Vol 13, Iss 1, p 12 (2020)
The leukotriene receptor antagonist Montelukast (MTK) is an approved medication for the treatment of asthma and allergic rhinitis. The existing marketed tablet forms of MTK exhibit inconsistent uptake and bioavailability, which partially explains the
Externí odkaz:
https://doaj.org/article/d279cd5aca4d49dc9d202c2b31f9139c
Autor:
Horst Zerbe, Nadine Paiement, Ludwig Aigner, Diana M. Bessa de Sousa, Erick Gonzalez-Labrada, Birgit Hutter-Paier, Rodolphe Obeid, Conway Justin W, Thomas K. Felder, Johanna Michael, Julia Tevini
Publikováno v:
Pharmaceutics
Volume 13
Issue 1
Pharmaceutics, Vol 13, Iss 12, p 12 (2021)
Volume 13
Issue 1
Pharmaceutics, Vol 13, Iss 12, p 12 (2021)
The leukotriene receptor antagonist Montelukast (MTK) is an approved medication for the treatment of asthma and allergic rhinitis. The existing marketed tablet forms of MTK exhibit inconsistent uptake and bioavailability, which partially explains the
Publikováno v:
Alzheimer's & Dementia. 14
Autor:
Rodolphe Obeit, Ludwig Aigner, Julia Marschallinger, Conway Justin W, Horst Zerbe, Nadine Paiement
Publikováno v:
Alzheimer's & Dementia. 13
Autor:
Horst Zerbe, Annette Katharina Zimmer, Jörg Kreuter, Patricia Chetoni, Marco Fabrizio Saettone
Publikováno v:
Journal of Controlled Release. 33:31-46
The aim of the present investigation was to investigate the influence of various polymers at different concentrations on the in vivo activity of pilocarpine-loaded albumin nanoparticles. It was speculated that co-administration with viscous or bioadh
Publikováno v:
Journal of Controlled Release. 32:57-70
The loading of pilocarpine on albumin microspheres and nanospheres was optimised. Optimal loading conditions were obtained with 2% pilocarpine and a particle concentration of 20 to 40 mg particles ml . Due to their high surface area nanoparticles exh
Autor:
Horst Zerbe, Markus Krumme
Publikováno v:
Drugs and the Pharmaceutical Sciences ISBN: 9780824708696
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c8b1f6bdc16506cec2e1a28776def6d
https://doi.org/10.1201/9780203910337.ch6
https://doi.org/10.1201/9780203910337.ch6